Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ANAPC11 Mouse anti-Human, Clone: OTI3F5, liquid, TrueMAB™
SDP

Mouse Monoclonal Antibody

Supplier:  OriGene TA506323S

Encompass_Preferred

Catalog No. 50-167-6568


Add to Cart

Description

Description

Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of ′Lys-11′-linked polyubiquitin chains and, to a lower extent, the formation of ′Lys-48′- and ′Lys-63′-linked polyubiquitin chains. May recruit the E2 ubiquitin-conjugating enzymes to the complex.
Specifications

Specifications

ANAPC11
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Q9NYG5
ANAPC11
Full length human recombit protein of human ANAPC11 produced in HEk293T cell.
30 μL
Primary
Human
Antibody
IgG1
Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
OTI3F5
Unconjugated
ANAPC11
APC11, Apc11p, HSPC214
Mouse
Affinity Chromatography
RUO
51529
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit